Presence of Bacterial DNA in Thrombotic Material of Patients with Myocardial Infarction by Piñón-Esteban, Pablo et al.
1
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:16299  | https://doi.org/10.1038/s41598-020-73011-5
www.nature.com/scientificreports
presence of bacterial DnA 
in thrombotic material of patients 
with myocardial infarction
p. piñon‑esteban 1*, L. núñez2, R. Moure3, G. M. Marrón‑Liñares2, X. flores‑Rios1, 
G. Aldama‑Lopez1, J. Salgado‑fernandez1, R. calviño‑Santos1,4, f. Rebollal‑Leal1, 
R. pan‑Lizcano2, n. Vazquez‑Gonzalez1,4, G. Bou3, M. tomás3, M. Hermida‑prieto2 & 
J. M. Vazquez‑Rodriguez1,4
infectious agents have been suggested to be involved in etiopathogenesis of Acute coronary 
Syndrome (AcS). However, the relationship between bacterial infection and acute myocardial 
infarction (AMI) has not yet been completely clarified. The objective of this study is to detect bacterial 
DnA in thrombotic material of patients with AcS with St‑segment elevation (SteMi) treated with 
Primary Percutaneous Coronary Intervention (PPCI). We studied 109 consecutive patients with STEMI, 
who underwent thrombus aspiration and arterial peripheral blood sampling. testing for bacterial DnA 
was performed by probe-based real-time Polymerase Chain Reaction (PCR). 12 probes and primers 
were used for the detection of Aggregatibacter actinomycetemcomitans, Chlamydia pneumoniae, 
viridans group streptococci, Porphyromonas gingivalis, Fusobacterium nucleatum, Tannarella forsythia, 
Treponema denticola, Helycobacter pylori, Mycoplasma pneumoniae, Staphylococus aureus,  Prevotella 
intermedia and Streptococcus mutans. Thus, DNA of four species of bacteria was detected in 10 of the 
109 patients studied. The most frequent species was viridans group streptococci (6 patients, 5.5%), 
followed by Staphylococus aureus (2 patients, 1.8%). Moreover, a patient had DNA of Porphyromonas 
gingivalis (0.9%); and another patient had DNA of Prevotella intermedia (0.9%). Bacterial DNA was not 
detected in peripheral blood of any of our patients. in conclusion, DnA of four species of endodontic 
and periodontal bacteria was detected in thrombotic material of 10 STEMI patients. Bacterial DNA 
was not detected in the peripheral blood of patients with bacterial DnA in their thrombotic material. 
Bacteria could be latently present in plaques and might play a role in plaque instability and thrombus 
formation leading to AcS.
Infectious agents have been suggested to play a role in chronic inflammation, which is involved in the etiopatho-
genesis of  atherosclerosis1. The infection/atherosclerosis paradigm has been studied since the 1970s. A number of 
findings associate pathogens with  atherosclerosis2, namely: (a) pathogens have been found in human atheroscle-
rotic  vessels3; (b) infection has been reported to lead to  atherosclerosis4 in animal studies; (c) seroepidemiological 
studies have demonstrated an association between pathogen- specific antibodies and  atherosclerosis5. Multiple 
pathogens have been documented to be involved in these associations, including species of bacteria such as 
Chlamydia pneumoniae, Helicobacter pylori, and periodontal  pathogens1.
Of these infectious agents, the pathogen which association with atherosclerosis has been most extensively 
studied is Chlamydia pneumoniae, with different results. Chlamydia pneumoniae was the first infectious organism 
to be found in cells of human atherosclerotic plaques, but rarely in normal arterial cells. It is also one of the few 
agents detected in plaques from which viable organisms have been  isolated3,6–10. However, antibiotic treatment 
open
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against Chlamydia pneumoniae has shown no benefit in secondary prevention of coronary  events11. Helicobacter 
species have also been found by Polymerase Chain Reaction (PCR) in biopsy specimens from coronary plaques 
of patients who underwent coronary artery bypass  grafting12.
Regarding oral bacteria, a large number of infectious agents have been associated with an increased risk for 
cardiovascular disease. Periodontal bacteria have been detected in atherosclerotic plaques in coronary arteries 
by  PCR13,14. Periodontitis, a chronic tissue-destructive inflammatory disease predominantly caused by Gramm-
negative bacteria, has been associated with a higher risk for acute myocardial  infarction15 (AMI) and coronary 
heart  disease16. An obvious possibility is that these diseases are promoted by shared risk factors. Yet, periodontitis 
has been postulated—but not confirmed—to cause cardiovascular disease.
Two recent studies have demonstrated the presence of DNA of periodontal and endodontic bacteria in 
thrombotic material of patients with Acute Coronary Syndrome with ST-segment Elevation (STEMI) treated 
with Primary Percutaneous Coronary Intervention (PPCI). In one of these studies, Ohki et al17 included 81 
patients and analyzed the presence of five periodontal bacteria, of which they detected three species: Aggregati-
bacter actinomycetemcomitans, Porphyromonas gingivalis and Treponema denticola. In another study, Pessi et al.18 
confirmed the presence of DNA of bacteria typically involved in endodontic infection, mainly oral viridans 
streptococci, and of periodontal pathogens in thrombotic material of 101 STEMI patients.
Hence, there is no agreement about the association between some microorganisms and AMI. The aim of 
our study is to investigate the presence of DNA of bacteria typically involved in chronic inflammation such as 
Chlamydia pneumoniae, Helicobacter pylori, and Mycoplasma pneumoniae, and of periodontal and endodontic 
bacteria in thrombotic material and peripheral blood of STEMI patients treated with Primary Percutaneous 
Coronary Intervention in a reference hospital in Spain.
Methods
patients inclusion. The sample of this study was composed of 175 consecutive patients with STEMI treated 
with PPCI in which intracoronary thrombus was obtained through catheter aspiration, in A Coruña Univer-
sity Hospital, Spain, between March 2013 and January 2016. Thrombi were removed by aspiration and arterial 
peripheral blood was sampled. Aspiration of thrombi from the culprit artery using sterile equipment (Export 
Catheter, Medtronic) was part of the standard management of AMI in our center. Following aspiration, the 
aspirate was poured into a pyrogen-free Eppendorf tube. In total, 5 mL of blood was extracted via the arterial 
sheath and subsequently stored. The thrombotic material was immediately stored in liquid Nitrogen. Blood 
samples were frozen at – 80 °C until analysis. Percutaneous coronary intervention was performed according to 
local standards. Aspirate sampling did not affect patients’ treatment. The study was approved by the "Comité ético 
de investigación de Galicia" (Reference: 2012/222) and conforms to the ethical standards of the Declaration of 
Helsinki. Written informed consent to aspirate sampling and DNA testing was obtained. Samples were registered 
in the biobank of samples for research on hemodynamics of the National Biobank Network of Carlos III Health 
Institute (C.0002483).
Clinical data including the presence of major coronary risk factors, severity of coronary artery disease, 
location of AMI, and prognosis during follow-up were recorded to compare groups according the presence of 
bacterial DNA (positivity/negativity, DNA [+] and [−] groups).
DnA extraction. DNA was extracted from frozen thrombotic material using the Illustra DNA Extraction 
Kit BACC3 (GE Healthcare) following the protocol, with minor modifications. Mechanical tissue disaggregation 
was specifically designed for preparing thrombotic material for DNA extraction. DNA purity and concentration 
were measured using a NanoDrop spectrophotometer. The minimum quality (ng/µL) and purity values (ratio 
260/280) accepted for qPCR analysis were 5 and 1.5, respectively. Genomic DNA was isolated from peripheral 
blood with Gentra Puregene Blood Kit (Qiagen), as previously  described19,20, only in patients with a bacterial 
DNA-positive thrombus (DNA [+]).
Bacterial DnA detection primers and probe design. A collection of primers and a set of UPL short 
probes (Roche Molecular Systems Inc., Pleasanton, CA, USA) were designed in order to detect the oral patho-
gens most frequently found in coronary thrombotic material (Table 1). A positive Beta globin control was used 
to verify the validity of the extraction and amplification procedure (primers described in Table 1). Likewise, a 
negative control including distilled water instead of the DNA template was used to verify the absence of reagent 
contamination.
Real‑time pcR. Thermal cycling was carried out using the LightCycler 480 II system (Roche Molecular 
Systems Inc.). Each reaction was prepared for singleplex assay—a pathogen per reaction—by mixing 5 µL of the 
DNA template with 10 µL of master mix (LightCycler 480 Probes Master; Roche Molecular Systems Inc.); 2.8 
µL of RNase free distilled water; 0.75 µL of primers (forward and reverse; 20 µM each), 0.5 µL of the UPL probe; 
and 0.2 µL of Uracyl N-glycosilase (Arcticzymes AS, Norway) to minimize the risk of contamination due to per-
sistent templates. The mixture was dispensed in a 96-well microtiter plate sealed with foil (Roche Molecular Sys-
tems Inc.) for 5-min incubation at room temperature for UNG activation. The real-time PCR protocol consisted 
of initial preincubation for enzyme activation (Fast-start) at 95 °C for 10 min, and 45 cycles of denaturation at 
95 °C for 10 s, 60 °C for 20 s for annealing, and 1 s of elongation at 72 °C, followed by a cooling hold of 10 s at 40 
°C. The LightCycler 480 II system could yield three possible results for target detection, namely: positive when 
a signal was detected at a Ct < 40; negative if no signal was detected at Ct > 45; and an indeterminate result if a 
signal was detected at a late Ct (40 < Ct < 45).
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Statistical analysis. SPSS version 19.0 was used for statistical analysis (IBM SPSS Statistics, Chicago, 
IL, USA). Continuous variables are presented either as mean (Standard Deviation [SD]) or as median values 
(interquartile range [IQR]). Categorical variables are expressed as absolute and relative frequencies (percent-
ages). Associations between the presence of bacterial DNA (positivity/negativity) in the sample and clinical 
and angiographic parameters were calculated using Fisher’s exact test. To calculate event-free survival, Kaplan 
Meier curves and log Rank Tests were used. Mann–Whitney U Test was used for comparison of non-parametric 
numerical variables. A value of p < 0.05 was considered statistically significant.
Results
Samples from 175 patients were analyzed. A total of 66 patients were excluded, as the DNA extracted from 
thrombus aspirates did not reach the quality and purity standards established. Finally, we analyzed the samples of 
109 patients, who constituted the study group. Baseline characteristics of study population are shown in Table 2. 
The 109 patients with STEMI received antithrombotic therapy with Acetilsalicic Acid, Clopidogrel, Ticagrelor 
or Prasugrel, according to the local AMI management protocol.
presence of bacterial DnA in thrombi from AMi patients. Of the 10 microorganisms tested, DNA 
of four different species of bacteria was detected in 10 thrombus samples (9.2%) of the 109 patients studied. The 
bacterial DNA most frequently detected corresponded to viridans group streptococci, which was identified in six 
of the 109 patients examined (5.5%). The species of some bacteria could not be identified due to the low DNA 
concentration extracted. Yet, we are certain that the species that could not be identified did not correspond to 
Streptoccus mutans, since we used probes and primers for the amplification of this species. Two typical species of 
microbiota in periodontal disease, Porphyromonas gingivalis and Prevotella intermedia, were identified in throm-
botic material of two patients. Moreover, DNA from Staphyloccus aureus was detected in two patients (1.8%). 
We did not find bacterial DNA in peripheral blood of patients with bacterial DNA in their thrombotic material.
Table 1.  Species specific primers and probes to detect ADN from different bacterias. Fw forward, Rv reverse, 
UPS universal probe library.
Oral pathogens Not oral pathogens
viridans group Streptococci
Fw: TCC GTA AAC AAT TGG ACG AA
Rv: CAC GTT GGA TAC CAC GAA GA
Probe: 67 UPS
Helicobacter pylori
Fw: CCA ATG GTA AAT TAG TTC CTG GTG 
Rv: GGT CTG TCG CCA ACA TTT TT
Probe: 155 UPS
Streptococcus mutans
Fw: GGG TTC TAA GCG CCA CAT T
Rv: CGA ACT AGT ACT GTT GTG GCT AGG 
Probe: 59 UPS
Chlamydia pneumoniae
Fw: CGT TGG CTA CGA AAG ATT CAG 
Rv: GGG TAA AGA ATA ACG AGC ACCA 
Probe: 67 UPS
Staphylococcus aureus
Fw: CCT TTT GTA GAC TCT TCG TCA AAT TC
Rv: CAT CAC GCT GAT GTT GTT GA
Probe: 49 UPS
Micoplasma pneumoniae
Fw: GCA GCT AAT GTC CGT AGT GCT 
Rv: GTG GTG AGC ATG ACC AGG TT
Probe: 150 UPS
Porphyromonas gingivalis
Fw: ATA GTA GCG TGT CCG GCT TC
Rv: ATC GTA GGC GGA TTG GAG A
Probe: 82 UPS
Fusobacterium nucleatum
Fw: TCC CAG CAA ATG TTG GAA G
Rv: TTC ATC ATC AAA TTC GTC ATA GTC T
Probe: 143 UPS
Treponema denticola
Fw: GCA GAT ATA CAG GTA GAC ATA GGA AGC 
Rv: GCT CTT CTA AGT CCT GTT CAG TGT T
Probe: 128 UPS
Prevotella intermedia
Fw: TGG TAT CAA AAT CAG CAA GGAA 
Rv: CGT CTT CGC GCA TAT TCA G
Probe: 126 UPS
Tannerella Forsythia
Fw: AAA CAT CGT GGA TAC CCT CCT 
Rv: ATC AAA GTG GTC GGT GTC G
Probe: 70 UPS
Aggregatibacter actinomycetemcomitans
Fw: CAA TAC TAC GGT GGT GCA GTA TCT 




Fw: CAA ATA AAG GAC AGT GCA GAA ATC 
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Regarding the association between bacterial DNA and clinical and angiographic characteristics, no differ-
ences were found based on age, sex, infarct location, number of vessels diseased, presence of diabetes mellitus 
or other risk factors (Table 3). Two patients had recent exposure to antibiotics; one of them, the patient in whom 
DNA of Porphiromonas gingivalis was detected in the intracoronary thrombus, was receiving treatment with 
Amoxicillin for an infection of the upper respiratory tract; the other patient was receiving Norfloxacin treatment 
and no bacterial DNA was found in this patient.
The median follow up was 420 days and no significant differences in outcomes were observed between DNA 
[+] and DNA [−] patients in terms of events during follow-up; during this period there were six deaths (6.1%) 
in the DNA [−] group and one death (10%) in the DNA [ +] group; three non-fatal AMI (3.1%) in the DNA [−] 
group and one non-fatal AMI in the DNA [+] group.
Table 2.  Baseline Characteristics of study population. MI myocardial infarction, LAD left anterior descending 
artery, LCx left circumflex, RCA right coronary artery, SD Standard Deviation
Baseline characteristics N = 109
Age (years mean ± SD) 61.4 ± 14.1
Male (%) 83 (76.1%)
Smokers (%) 41 (37.6%)
Hypertension (%) 47 (43%)
Dyslipidaemia (%) 36 (33%)
Diabetes mellitus (%) 14 (12.8%)
Prior MI (%) 6 (5.5%)
Anterior MI (%) 38 (35%)
Inferior MI (%) 52 (47.7%)
Radial access (%) 93 (85%)





Success procedure (TIMI III) 94%
Table 3.  Differences between DNA ( +) and DNA (-) groups. Associations between the presence of bacterial 
DNA (positivity/negativity) in the sample and clinical and angiographic parameters were calculated using 
Fisher’s exact test. Mann–Whitney U Test was used for comparison of non-parametric numerical variables. A 
value of p < 0.05 was considered statistically significant. MI myocardial infarction, LAD left anterior descending 
artery, LCx left circumflex, RCA right coronary artery.
Baseline characteristics
No bacterial DNA in thrombotic material Bacterial DNA in thrombotic material
pn = 99 n = 10
Age (years mean ± SD) 61.4 ± 14.2 61.6 ± 13.0 0.97
Male (%) 75 (75.8%) 8 (80.0%) 0.55
Smokers (%) 37 (37.4%) 4 (40.0%) 0.56
Hypertension (%) 43 (43.4%) 4 (40.0%) 0.55
Dyslipidaemia (%) 34 (34.3%) 2 (20.0%) 0.29
Diabetes mellitus (%) 11 (11.1%) 3 (30.0%) 0.11
Prior MI (%) 5 (5.1%) 1 (10%) 0.44
Anterior MI (%) 45 (48%) 4 (40%) 1.0
Inferior MI (%) 48 (52%) 4 (40%) 1.0
Radial access (%) 86 (86.9%) 7 (70%) 0.16
Multivessel disease 39 (36.4%) 4 (40%) 0.53
Infarct related artery
LAD (%) 47 (47%) 4(40%) 0.74
LCx (%) 12 (12.1%) 1 (10%) 1.0
RCA (%) 38 (38%) 5 (50%) 0.512
Success procedure (TIMI III)
92 (93%) 9 (90%) 0.50
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Discussion
Our results confirm the presence of bacterial DNA in the thrombotic material of patients with AMI. In the pre-
sent study, 9.2% of thrombus samples contained bacterial DNA, mainly from viridans group streptococci, which 
are typically involved in endodontic infection. Notably, we detected DNA of other endodontic bacteria—such as 
Staphylococcus aureus—and periodontal pathogens—as Porphyromonas gingivalis or Prevotella intermedia. In our 
study, the peripheral blood of patients was only analyzed when their thrombus was positive for bacterial DNA. 
It is important to note that the absence of bacterial DNA in peripheral arterial blood automatically excluded 
the presence of active clinically-silent bacteriemia at the moment of MI. Besides this, potential contaminations 
during sampling can be confidently excluded, since thrombotic material and peripheral blood were collected 
using the same procedure.
Our results are consistent with those reported in two recent studies in patients with AMI conducted in Japan 
and Finland. Ohki et al.17 analyzed thrombotic material of 81 patients with AMI treated with PPCI. The authors 
investigated the presence of five periodontal bacteria by PCR and detected three species, namely: Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis and Treponema denticola in 18 patients (22.2%). Pessi et al.18 
analyzed thrombotic material and arterial blood of 101 AMI patients undergoing PPCI by real-time quantitative 
PCR. The authors investigated the presence of oral bacteria and DNA of Chlamydia pneumoniae. In this study, 
DNA of bacteria generally found in endodontic infection—mainly oral viridans group streptococci—was detected 
in 78.2% of samples, whereas periodontal pathogens were detected in 34.7%. In agreement with our results, Pessi 
et al. did not find DNA of Chlamydia pneumoniae either. Therefore, DNA of similar oral pathogens was found in 
thrombotic material in the three studies, whereas DNA of bacteria traditionally related to the etiopathogenesis 
of atherosclerosis was not detected.
Although numerous seroepidemiological, histopathological, and animal studies have associated Chlamydia 
pneumoniae with atherosclerosis, we did not find DNA of Chlamydia pneumoniae in our patients. Chlamydia 
pneumoniae is the species of bacteria linked to atherosclerosis that has been most widely studied. Several tech-
niques have been used to detect the presence of this species of bacteria in vascular  tissues21, including PCR, 
electron microscopy, and immunocytochemistry. However, the results of previous studies vary greatly, and 
there are no reports of the presence of Chlamydia pneumoniae in thrombotic material of patients with AMI. 
We did not find other microorganisms reportedly associated with atherosclerosis, as Helycobacter pylori and 
Mycoplasma pneumoniae.
Numerous studies have related oral disease and cardiovascular events. The relationship between periodontitis 
and cardiovascular disease was assessed in the PAROKRANK  STUDY15. This case–control study including 805 
patients with a first episode of AMI revealed after adjustment for confounding factors that the risk for this first 
episode of AMI was significantly higher in patients with periodontitis.
Differences in the percentage of samples with bacterial DNA between our study and previous studies could 
be explained by several reasons. The first reason is methodological, as one of the studies sampled intracoronary 
thrombus and 2 ml of intracoronary blood  samples17, whereas we sampled only intracoronary thrombotic mate-
rial. If we had collected coronary blood as did Okhi et al., the detection rate might have been higher to the one 
obtained. Another factor that could explain variability of results is epidemiological, with differences in dental 
health and incidence of periodontal disease between study populations. In the study published by Pessi et al. 
30 patients (29.5%) were referred for a dental panoramic tomography. These tomographies showed a periapical 
abscess in 46.6% of patients. A significant association was observed between periapical abscess confirmed by 
tomography and the detection of streptococcus mitis group in thrombotic material.
In our study, seven of the ten patients with DNA (+) thrombus material had a history of tooth extraction. 
The reason of extraction was periodontitis in two patients, and unknown in the others. Examining differences in 
the incidence of periodontal infection between the DNA (+) and DNA (−) groups would have been of interest.
There were no differences between groups regarding their clinical characteristics. We observed a non-signif-
icant trend towards a higher prevalence of Diabetes Mellitus in the DNA (+) group, which is a well-known risk 
factor for dental infection. However, the small sample limits the statistical power of analyses. Although some 
reports suggest a relationship between severity of coronary disease and dental  infection22, no differences were 
observed in our study between the DNA (+) and DNA (−) group regarding the severity or extent of coronary 
artery disease or other clinical characteristics. These results are consistent with the ones of the studies published 
by Okhi et al. and Pessi et al.
In relation to prognosis, no differences were documented in outcomes based on the presence or not of bacte-
rial DNA in thrombotic material. Thus, there were no differences between groups in mortality rates, occurrence 
of a new AMI, or stent thrombosis during follow-up. However, these results are influenced by the small size of 
the sample and low number of events.
There are around 1000 different species in the oral cavity, which are prevailingly streptoccci23. Viridans strep-
tococcus is a pseudotaxonomic non-Linnean term for a group of human commensals most commonly present in 
the oral cavity. These bacteria have several properties that indicate that, rather than being an innocent bystander 
in atherosclerosis, they could play an active role in the development of the disease. Such bacteria would be 
latently present in plaques and be involved in plaque instability, which leads to subsequent thrombus formation 
and cause Acute Coronary Syndrome. Whether these bacteria have a role in the atherosclerotic plaque rupture 
associated with acute coronary syndromes remain to be determined. Also, it is unknown whether these bacteria 
promote the atherosclerotic plaque or attach to existing atherosclerotic lesions. It has been suggested that these 
microorganisms trigger the production of inflammatory cytokines, monocyte chemoattractant  proteins24, and the 
accumulation of macrophages by the activation of the CD14/Toll-like receptor 2  complex25. They are able to attach 
to different surfaces and generate a biofilm, thereby enabling other bacteria to infitrate  tissue26. These micro-
organisms also have thrombogenic properties with potential to initiate or contribute to platelet  aggregation27. 
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Porphyromonas gingivalis (PG) has been reported to hydrolyze a fibrous cap and, as viridans streptococci, it can 
induce platelet  aggregation28. After plaque rupture, bacteria may be released into the blood stream and induce 
platelet aggregation. Also, these bacteria can be detected in thrombotic material as demonstrated by Pessi et al., 
who found the bacteria in 3 of the 9 thrombotic material samples detected by transmission electron microscopy. 
The route by which these microorganisms reach atherosclerotic lesions remains unclear. Bacteriemia originated 
in the oral cavity is the most widely accepted theory. After oral manipulation, like tooth extraction or simply 
tooth brushing, the patient can develop transient bacteriemia, which is usually subclinical and mostly caused 
by viridans streptococci29,30. Several studies have shown that patients with periodontitis are at a higher risk for 
 bacteriemia31,32, and some living microorganisms may reach coronary lesions. Bacteria may reach atherosclerotic 
lesions directly through the endothelium and be phagocytosed by T-cells and finally translocated into an athero-
sclerotic plaque. Numerous repeated bacteriemias or other bacterial infections during lifetime would contribute 
to accumulate pathogens in atherosclerotic lesions, thereby contributing to the development of chronic low-grade 
inflammation. T-cell mediated release of proinflammatory mediators and proteolytic substances in response to a 
chronic low- grade bacterial infection may be the mechanism by which thrombosis is induced. In our study, we 
only investigated the presence of bacterial DNA in thrombotic material, but we did not find bacterial DNA in 
peripheral blood. This finding could suggest the presence of a local mechanism of action where bacteria could 
play a role in the development of acute coronary syndromes. Thus, the DNA detected may correspond to living 
bacteria present in the coronary atheroma, rather than from phagocytic cells from circulation.
Limitations
The present study has several limitations. Firstly, not all thrombi could be studied, as 66 of the 175 samples were 
excluded. In addition, the amount of material obtained from some patients was limited. Secondly, due the limited 
sampled obtained by aspiration, we were not able to identify species level 6 microorganisms of the viridans group 
streptococci. Finally, as previously mentioned, we could not collect comprehensive clinical details regarding oral 
disease in our population, which would have provided relevant information.
conclusion
To the best of our knowledge, this is the largest observational study ever performed on the relationship between 
the presence of DNA of endodontic and periodontal microorganisms in thrombotic material in myocardial 
infarction. DNA of four species of endodontic and periodontal bacteria was detected in the thrombotic material 
of 10 STEMI patients. Bacterial DNA was not detected in the peripheral blood of patients with bacterial DNA 
in their thrombotic material. This finding suggests that endodontic and periodontal bacteria could be latently 
present in plaques and might play a role in plaque instability and subsequent thrombus formation in a subset of 
patients, ultimately leading to ACS. This is a pilot study. The role of bacterial infection in coronary events remains 
unclear. More research is needed to determine the relationship between oral infection and acute coronary events, 
and assess the potential preventive role of dental care in myocardial infarction.
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